Physician profile
Christopher Chipko
NPI 1801206818
$862.16
in general payments reported to CMS, 2019-2025
15 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $41.56 · 2021: $35.22 · 2022: $13.74 · 2023: $265 · 2024: $213 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $223.34 | 2019-2024 | Rezum Generator, Spaceoar Vue System - 10ml |
| Blue Earth Diagnostics | $150.16 | 2023 | |
| Siemens Medical Solutions USA, INC. | $117.47 | 2025 | Varian Ethos Treatment Planning, Eclipse Treatment Planning System For External Beam Radiation Therapy, Aria Radiation Therapy Management Software |
| Novocure INC. | $107.14 | 2019 | |
| Progenics Pharmaceuticals, INC. | $43.76 | 2023-2024 | Pylarify |
| Isoray, INC | $39.62 | 2023 | Brachytherapy Source |
| Abbvie INC. | $33.05 | 2024 | |
| Merck Sharp & Dohme LLC | $27.43 | 2023 | Lynparza, Keytruda |
| Olympus America INC. | $21.64 | 2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $19.09 | 2019 | |
| Pfizer INC. | $17.64 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $17.58 | 2021 | |
| Varian Medical Systems, INC. | $16.81 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.74 | 2022 | |
| Teleflex LLC | $13.69 | 2023 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chipko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.